CAPILLARY Capillary Technologies India Q4 FY26 results (Jan–Mar 2026) and concall
Capillary Technologies reported a strong Q4 and full-year FY26, driven by robust revenue growth, improved adjusted EBITDA margins, and high net retention rates. The company successfully closed the acquisition of SessionM, a $35 million business, which is expected to propel FY27 revenue to INR 1,000-1,050 crores. While short-term margin pressures are anticipated due to integration and salary hikes, management remains confident in achieving steady-state EBITDA margins of 25-30% through continued organic growth and efficient acquisition integration.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 31.4%, net profit up 40.2% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 42 | 49 | 42 | 47 | 58 +37% | 65 +31% |
| EBITDA | 9 | 15 | 6 | 8 | 10 +16% | 16 +5% |
| Net profit | 0 | 7 | -5 | -3 | 1 +950% | 10 +40% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
